UCB SA (UCBJY) Comparison with companies in other sectors?

UCB SA has a share price of 386.68M. You can analyze UCB SA (UCBJY) competitors across different market sectors through stock heatmaps.

What are UCBJY's NET and operating margins?

UCB SA (UCBJY) operating margin is around 0.09, and net profit margin is approximately 0.04 as of the latest reports.

In what way does UCBJY's earnings per share (EPS) trend reflect its financial momentum?

UCB SA (UCBJY) EPS is 3.22 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for UCB SA is 31.57, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for UCB SA?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for UCB SA like P/E which is 141.07, P/B which is 3.38, and PEG which is -5.17. Compare them with sector averages to evaluate if the stock is priced fairly.

UCB SA

UCBJY•PNK

Healthcare

Biotechnology

$101.66

$0.51(0.50%)

Fundamental Analysis of UCB SA (UCBJY)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$3.22

P/E Ratio

31.57

ROE

0.03%

Net Margin

0.04%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$39.31B

Shares OutstandingTotal number of shares issued

$386.68M

Book Value/ShareNet worth per share

$51.11

Revenue/ShareAnnual revenue per share

$27.79

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$3.22

Net MarginNet income as percentage of revenue

4.40%

Operating MarginOperating income as percentage of revenue

9.15%

ROEReturn on shareholders' equity

2.53%

ROAReturn on total assets

1.38%

ROCEReturn on capital employed

3.61%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$2.92

Cash/ShareCash and equivalents per share

$8.95

FCF YieldFree cash flow as percentage of market cap

1.71%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.67

Dividend YieldAnnual dividend as percentage of stock price

0.78%

Financial Ratios Analysis data is not available for UCBJYFinancial Ratios Analysis details for UCBJY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for UCBJYSector Benchmarking details for UCBJY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for UCB SA Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of UCB SA. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account UCB SA's unique business strengths and challenges.

Key Financial Metrics for UCB SA

For UCB SA, essential financial indicators include EPS 3.22, PE 31.57, and ROE 0.03. These key ratios reveal insights into UCB SA's profitability, valuation, and operational health. Understanding these metrics enables you to compare UCB SA with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of UCB SA

Metrics like Net Margin 4.40% and ROA 1.38% shed light on how well UCB SA is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether UCB SA can sustain its operations and continue growing in the future.

Valuation and Market Position of UCB SA

Using ratios such as P/B Ratio 3.38 and PEG Ratio -5.17, investors can assess whether UCB SA is appropriately valued based on its financials and growth potential. These figures, combined with UCB SA's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for UCB SA

Financial health indicators, such as Debt/Equity Ratio 0.30 and Cash Flow $2.92, provide a snapshot of UCB SA's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like UCB SA, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for UCB SA

Investing in UCB SA based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at UCB SA focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;